Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients.
https://on.wsj.com/3MNQiQe The Wall Street JournalRobert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients.
https://on.wsj.com/3MNQiQe The Wall Street Journal